Status: Recruiting
A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healthy Overweight/Obese Participants
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of LAE103 injection in healthy overweight/obese participants or healthy postmenopausal women. Study will also evaluate the safety, tolerability and preliminary pharmacodynamic effect of multiple dose injections in overweight/obese participants. In addition, the study will also investigate the safety, tolerability of a single-dose co-administration of LAE102 and LAE103 in healthy overweight/obese participants.
Participants needed: 104
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Laekna LimitedUpdated: Jan 20, 2026Locations: 1
Eligibility criteria
Are capable of giving signed informed consent and comply with the requirements a... [+6]
Have a history or presence of clinically significant medical condition(s). [+24]